The connections between vascular calcification and bone health

被引:107
作者
Cannata-Andia, Jorge B. [1 ]
Roman-Garcia, Pablo [1 ]
Hruska, Keith [2 ]
机构
[1] Univ Oviedo, Inst Reina Sofia Invest Nefrol, RedinRen ISCIII, Hosp Univ Cent Asturias,Bone & Mineral Res Unit, Oviedo, Spain
[2] Washington Univ, Div Pediat Nephrol, St Louis, MO USA
关键词
CHRONIC KIDNEY-DISEASE; CORONARY-ARTERY CALCIFICATION; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; AORTIC CALCIFICATION; VITAMIN-D; PARATHYROID-HORMONE; MINERAL METABOLISM; OSTEOPOROTIC FRACTURES; EXTRACELLULAR CALCIUM;
D O I
10.1093/ndt/gfr591
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Vascular calcification, bone loss and increased fracture risk are age-associated disorders. Several epidemiological studies have suggested a relationship between vascular calcification, impaired bone metabolism and increased mortality. So far, this relationship had been under-estimated as osteoporosis and vascular calcification have been considered non-modifiable disorders of aging. Recent data suggest that this association is not simply an artefact of age, stressing that the co-incidence of vascular calcification with low bone activity and osteoporosis could be biologically linked. During the development of vascular calcification, the transition of vascular smooth muscle cells towards an osteoblast-like phenotype promotes the release of the vesicular structures and mineralization within these structures is promoted by several players, including those related to mineral metabolism, like phosphorus, calcium or parathyroid hormone, which influence either the supersaturation within the structure or the expression of osteogenic factors. However, an intriguing question is whether the presence of vascular calcification impacts bone metabolism, thus demonstrating true crosstalk between these tissues. Evidence is now emerging, suggesting that some inhibitors of the Wnt pathway, such as secreted frizzled Proteins 2 and 4 and Dickkopf related protein-1 (DKK-1), may play a role linking vascular calcification and bone loss. An additional important question to answer, from the patient's perspective, is whether or not progression of vascular calcification can be prevented or restricted and whether altering this progression we can efficiently impact patients' outcomes. Much evidence suggests that the control of the chronic kidney disease-mineral and bone disorder components, particularly serum phosphorus, are the main targets to maintain normal bone turnover and protect against vascular calcification.
引用
收藏
页码:3429 / 3436
页数:8
相关论文
共 71 条
[1]   Low Bone Volume-A Risk Factor for Coronary Calcifications in Hemodialysis Patients [J].
Adragao, Teresa ;
Herberth, Johann ;
Monier-Faugere, Marie-Claude ;
Branscum, Adam J. ;
Ferreira, Anibal ;
Frazao, Joao M. ;
Curto, Jose Dias ;
Malluche, Hartmut H. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (02) :450-455
[2]   Aortic Msx2-Wnt calcification cascade is regulated by TNF-α-Dependent signals in diabetic Ldlr-/- mice [J].
Al-Aly, Ziyad ;
Shao, Jian-Su ;
Lai, Chung-Fang ;
Huang, Emily ;
Cai, Jun ;
Behrmann, Abraham ;
Cheng, Su-Li ;
Towler, Dwight A. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (12) :2589-2596
[3]  
Asci G, 2007, NEPHROL DIAL TRANSPL, V22, P217
[4]   Association of Changes in Bone Remodeling and Coronary Calcification in Hemodialysis Patients: A Prospective Study [J].
Barreto, Daniela Veit ;
Barreto, Fellype de Carvalho ;
de Carvalho, Aluizio Barbosa ;
Cuppari, Lilian ;
Draibe, Sergio Antonio ;
Dalboni, Maria Aparecida ;
Affonso Moyses, Rosa Maria ;
Neves, Katia Rodrigues ;
Jorgetti, Vanda ;
Miname, Marcio ;
Santos, Raul D. ;
Canziani, Maria Eugenia F. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (06) :1139-1150
[5]   Mineral metabolism, mortality, and morbidity in maintenance hemodialysis [J].
Block, GA ;
Klassen, PS ;
Lazarus, JM ;
Ofsthun, N ;
Lowrie, EG ;
Chertow, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08) :2208-2218
[6]   Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling [J].
Byon, Chang Hyun ;
Javed, Amjad ;
Dai, Qun ;
Kappes, John C. ;
Clemens, Thomas L. ;
Darley-Usmar, Victor M. ;
McDonald, Jay M. ;
Chen, Yabing .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (22) :15319-15327
[7]   Vascular calcifications:: Pathogenesis, management, and impact on clinical outcomes [J].
Cannata-Andia, Jorge B. ;
Rodriguez-Garcia, Minerva ;
Carrillo-Lopez, Natalia ;
Naves-Diaz, Manuel ;
Diaz-Lopez, Bernardino .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 :S267-S273
[8]   MINERAL METABOLISM Should cinacalcet be used in patients who are not on dialysis? [J].
Cannata-Andia, Jorge B. ;
Fernandez-Martin, Jose L. .
NATURE REVIEWS NEPHROLOGY, 2009, 5 (06) :307-308
[9]   Phosphorus and Survival: Key Questions That Need Answers [J].
Cannata-Andia, Jorge B. ;
Naves-Diaz, Manuel .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (02) :234-236
[10]   Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients [J].
Chertow, GM ;
Burke, SK ;
Raggi, P .
KIDNEY INTERNATIONAL, 2002, 62 (01) :245-252